Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics.

Farhad, Tasneem; Neves, Keila; Arbuthnot, Patrick; Maepa, Mohube Betty

Farhad, Tasneem; Neves, Keila; Arbuthnot, Patrick; Maepa, Mohube Betty.

Afiliação

Farhad T; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Neves K; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Arbuthnot P; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.
Maepa MB; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.

Genes (Basel) ; 13(11)2022 10 25.

Article em En | MEDLINE | ID: mdl-36360178

Assuntos

COVID-19; Hepatite B Crônica; Hepatite B; Vacinas Virais; Humanos; Vetores Genéticos/genética; Vírus da Hepatite B/genética; Hepatite B/genética; Hepatite B/prevenção & controle

Palavras-chave

adenovirus; gene therapy; hepatitis B virus; vaccine; viral vectors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Vacinas Virais / Hepatite B Crônica / COVID-19 / Hepatite B Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Genes (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google